Cardiac magnetic resonance imaging in daily practice in a peripheral medical centre: Description of the first 383 patients

Netherlands Heart Journal

Volumn 18, Issue 11, 2010, Pages 524-530

  Lexis, C P H ^a   Rahel, B M ^a   van Langen, H ^a   Lexis, M A S ^a   Hoffland, G A ^b   Post, P J M ^a   Meeder, J G ^a  

^a VIECURI MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cardiac gated imaging techniques; Cardiology; Magnetic resonance imaging

Indexed keywords

ADULT; AMYLOIDOSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EQUIPMENT DESIGN; FEMALE; HEART INFARCTION; HEART RIGHT VENTRICLE DYSPLASIA; HOSPITAL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL PRACTICE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOCARDIOGRAPHY; REVIEW; SARCOIDOSIS; TREATMENT PLANNING;

EID: 78649795151     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-010-0828-8     Document Type: Review

References (9)

1. Bruder O, Schneider S, Nothnagel D, et al. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol. 2009;54:1457-1466.
2. Kies P, Bootsma M, Bax J, Schalij MJ, van der Wall EE. Ar-rhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. Heart Rhythm. 2006;3:225-234.
3. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35.
4. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
5. Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ. 2006;175:911-917.
6. White JA, Patel MR. The role of cardiovascular MRI in heart failure and the cardiomyopathies. Cardiol Clin. 2007;25:71-95, 6.
7. Choudhury L, Mahrholdt H, Wagner A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hyper-trophic cardiomyopathy. J Am Coll Cardiol. 2002;40:2156-2164.
8. Leonardi S, Raineri C, De Ferrari GM, et al. Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy. Eur Heart J. 2009;30:2003-2010.
9. Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/ SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiograp-hy and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006;48:1475-97.